Cresco Labs faced a class action lawsuit in Illinois after marketing products without the required FDA approval.
2 reports, 1 independent
Updated Jan 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cresco Labs faced a class action lawsuit in Illinois after marketing products without the required FDA approval.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- An Illinois company supplied a lethal cocktail to Georgia, following the FDA's approval of the original anesthetic drug.Sub-event
Cresco Labs marketed products without FDA approval, leading to a class action in Illinois.1 source
Keep exploring
The entities involved
- FDA
-
Cresco Labs
American cannabis company
-
Illinois
state of the United States of America
Related events
- Future sales of a product are contingent upon obtaining the necessary FDA registration and labeling, while the state simultaneously announces actions to remove regulatory barriers.
- FDA approval enables commercial opportunity involving CBRE Group.
- Policy calls for state adoption of federal standards in Illinois.
- FDA seeks to ease market restrictions while consumer companies Ferrara and Hershey innovate in premium product lines.
- FDA and Pfizer are seeking regulatory approval for their products.